Original Research

Chemotherapy with or without pemetrexed as second-line regimens for advanced non-small-cell lung cancer patients who have progressed after first-line EGFR TKIs: a systematic review and meta-analysis

Li ZH, Guo HY, Lu YY, Hu JX, Luo HT, Gu WG

OncoTargets and Therapy 2018, 11:3697-3703

Published Date: 27 June 2018